Literature DB >> 30985735

Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.

Juhan Lee1, Deok Gie Kim1, Jee Youn Lee1, Jae Geun Lee1, Dong Jin Joo1, Soon Il Kim1, Myoung Soo Kim1.   

Abstract

BACKGROUND: In June 2016, the Korean Network for Organ Sharing implemented a Model for End-stage Liver Disease (MELD) score-based allocation system to better prioritize deceased-donor liver transplant (DDLT) candidates. The aim of this study was to assess the impact of this allocation system.
METHODS: We compared waiting list and posttransplant outcomes during the first year of operation of the MELD allocation system (from June 2016 to May 2017) with an equivalent period before its implementation (from June 2015 to May 2016).
RESULTS: A total of 3041 candidates were listed for DDLT (1464 pre-MELD, 1577 post-MELD era) and 892 patients received DDLT during the study period. A decrease in waiting list mortality and an increase in DDLT rate were observed after MELD implementation. However, the number of living donor liver transplants did not differ significantly pre- to post-MELD. As was expected, introduction of the MELD allocation system increased mean MELD scores at DDLT (24.1 ± 8.3 pre-MELD, 34.5 ± 7.0 post-MELD era, P < 0.001). Posttransplant patient survival rates at 1-year were 79.9% in pre-MELD era and 76.2% in post-MELD era (P = 0.184). The proportion of interregional organ transfer increased from 25.1% to 40.5%. Furthermore, transplant benefits increased with MELD scores.
CONCLUSIONS: The MELD system was found to address the goal of fairness well. Implementation of the MELD system improved equity in terms of access to DDLT regardless of regions. Although a greater proportion of more severely ill patients received DDLT after MELD implementation, posttransplant survivals remained unchanged.

Entities:  

Mesh:

Year:  2019        PMID: 30985735     DOI: 10.1097/TP.0000000000002755

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea.

Authors:  Tae Jin Kwon; Wonseok Kang; Geum-Youn Gwak; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Dong Hyun Sinn; Seung Woon Paik
Journal:  Korean J Transplant       Date:  2021-03-31

2.  Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 years.

Authors:  Sang-Hyun Kang; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Jung-Man Namgoong; Young-In Yoon; Hui-Dong Cho; Jae-Hyun Kwon; Yong-Kyu Chung; Jin-Uk Choi; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2020-03-31

3.  The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study.

Authors:  Doo-Ho Lee; Yeon Ho Park; Seok Won Choi; Kug Hyun Nam; Sang Tae Choi; Doojin Kim
Journal:  Ann Surg Treat Res       Date:  2021-12-01       Impact factor: 1.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.